PAPER Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, Craig D, McGuinness B, Johnston J, Holmes C, Livingston G, Bass NJ, Gurling H, McQuillin A, , Holmans P, Jones L, Devlin B, Klei L, Barmada MM, Demirci FY, Dekosky ST, Lopez OL, Passmore P, Owen MJ, O'Donovan MC, Mayeux R, Kamboh MI, Williams J
SEARCH RESULTS
329939 RESULTS
John Kaiser
Denysias BioScienceRancho Santa Fe, United States
Geoffrey Johnson
Mayo ClinicRochester, United States
PAPER Bensman A, Milhaud G
[Persistent nephrotic syndrome in a child: blood levels of 25 hydroxyvitamin D].
Nouv Presse Med. 1979 Apr 7;8(16):1351. PubMed: 90364PAPER Kort J, Rendl KH
[Surgical treatment of cholelithiasis. Comparison of results 1953-1957 and 1968-1972].
Med Welt. 1977 Apr 29;28(17):812-6. PubMed: 875697PAPER Chadchankar H, Yavich L
Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein.
Brain Res. 2011 Nov 14;1423:67-76. PubMed: 22000591PAPER Cersosimo MG, Benarroch EE
Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers.
J Neurol Sci. 2012 Feb 15;313(1-2):57-63. PubMed: 22001247PAPER Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, Vance JM, Outeiro TF, Wang L, Borovecki F, Ferreira JJ, Oliveira SA
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.
PLoS One. 2011;6(10):e25443. PubMed: 22003392PAPER Rossi D, De Grandis E, Barzaghi C, Mascaretti M, Garavaglia B, Zanotto E, Morana G, Biancheri R
Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.
Brain Dev. 2011 Oct 13; PubMed: 21999968PAPER Gorąca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B
Lipoic acid- biological activity and therapeutic potential.
Pharmacol Rep. 2011;63(4):849-58. PubMed: 22001972PAPER Jeffrey M, Scholes SF, Martin S, McGovern G, Sisó S, González L
Increased Immunohistochemical Labelling for Prion Protein Occurs in Diverse Neurological Disorders of Sheep: Relevance for Normal Cellular PrP Function.
J Comp Pathol. 2011 Oct 13; PubMed: 22000036PAPER Calvello R, Panaro MA, Carbone ML, Cianciulli A, Perrone MG, Vitale P, Malerba P, Scilimati A
Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells.
Pharmacol Res. 2011 Oct 1; PubMed: 22001217PAPER Dhull DK, Bhateja D, Dhull RK, Padi SS
Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain.
J Chem Neuroanat. 2011 Oct 6; PubMed: 22001294PAPER Foti Cuzzola V, Ciurleo R, Giacoppo S, Marino S, Bramanti P
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries.
CNS Neurol Disord Drug Targets. 2011 Nov 1; PubMed: 21999735PAPER Sumioka A, Brown TE, Kato AS, Bredt DS, Kauer JA, Tomita S
PDZ binding of TARPγ-8 controls synaptic transmission but not synaptic plasticity.
Nat Neurosci. 2011 Nov;14(11):1410-2. PubMed: 22002768Current Filters
No filters selected